Section Arrow
SEPN.NASDAQ
- Septerna Inc
Quotes are at least 15-min delayed:2025/06/04 15:32 EDT
Last
 9.93
-0.04 (-0.40%)
Day High 
10.3394 
Prev. Close
9.97 
1-M High
11.36 
Volume 
366.62K 
Bid
9.93
Ask
9.97
Day Low
9.89 
Open
10.05 
1-M Low
6.415 
Market Cap 
444.25M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.55 
20-SMA 8.82 
50-SMA 7.2 
52-W High 28.99 
52-W Low 4.17 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.78/-2.39
Enterprise Value
467.87M
Balance Sheet
Book Value Per Share
8.98
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.08M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CLRBCellectar Biosciences0.4734+0.1958+70.53%-- 
NCNANuCana plc0.0454-0.0144-24.08%-- 
RXRXRecursion Pharmaceuticals4.9111+0.5211+11.87%-- 
HOTHHoth Therapeutics1.54+0.6202+67.43%-- 
SGMTSagimet Biosciences4.1911+0.5611+15.46%-- 
Quotes are at least 15-min delayed:2025/06/04 15:32 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.